What ADICET Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 3 |
| Sells | 0 | 4 |
| Total trades | 0 | 12 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 13,975 |
| Disposed | 0 | 354,869 |
| Net activity | +0 | −340,894 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ra Capital MANAGEMENT, L.p. | 10% owner | Apr 27 | Other Transaction · J | −250,000 | — | — | 932,624 |
| Orbimed Advisors Llc | 10% owner | Apr 08 | Open-market sale · S | −40,416 | $6.52 | −$264K | 0 |
| Orbimed Advisors Llc | 10% owner | Apr 08 | Open-market sale · S | −32,523 | $6.29 | −$205K | 0 |
| Orbimed Advisors Llc | 10% owner | Apr 07 | Open-market sale · S | −2,400 | $6.38 | −$15.3K | 32,523 |
| Orbimed Advisors Llc | 10% owner | Apr 07 | Open-market sale · S | −29,319 | $6.53 | −$191K | 34,923 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Feb 20 | Open-market buy · P | +74,751 | $7.27 | +$543K | 1,182,624 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Feb 19 | Open-market buy · P | +74,268 | $7.21 | +$535K | 1,107,873 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Feb 18 | Open-market buy · P | +74,577 | $7.04 | +$525K | 1,033,605 |
| Harvey Brian Nicholas | Chief Financial Officer | Jan 24 | Withheld — tax / exercise cost · F | −546 | $8.44 | −$4.61K | 5,145 |
| Healey Don | Chief Technology Officer | Jan 24 | Withheld — tax / exercise cost · F | −535 | $8.44 | −$4.52K | 3,452 |
| Schor Chen | President & CEO | Jan 24 | Withheld — tax / exercise cost · F | −1,755 | $8.44 | −$14.8K | 6,820 |
| Aftab Blake | Chief Scientific Officer | Jan 24 | Withheld — tax / exercise cost · F | −535 | $8.44 | −$4.52K | 2,981 |
| Orbimed Advisors Llc | 10% owner | Oct 08 | Open-market buy · P | +3,500,000 | $1.00 | +$3.5M | 4,490,254 |
| Orbimed Advisors Llc | 10% owner | Oct 08 | Open-market buy · P | +1,500,000 | $1.00 | +$1.5M | 9,026,359 |
| Peng Katie | Director | Jun 11 | Grant / award · A | +5,900 | — | — | 11,800 |
| Sinclair Andrew | Director | Jun 11 | Grant / award · A | +5,900 | — | — | 17,700 |
| Dubin Steve | Director | Jun 11 | Grant / award · A | +5,900 | — | — | 22,700 |
| Chodakewitz Jeffrey | Director | Jun 11 | Grant / award · A | +5,900 | — | — | 17,700 |
| Klickstein Lloyd | Director | Jun 11 | Grant / award · A | +5,900 | — | — | 108,566 |
| Harvey Brian Nicholas | Chief Financial Officer | Jan 24 | Withheld — tax / exercise cost · F | −8,752 | $0.92 | −$8.07K | 91,048 |
Loading...
